FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival

Bone

Volumn 42, Issue 6, 2008, Pages 1032-1039

  Dufour, Cécilie ^a,c   Guenou, Hind ^a,c   Kaabeche, Karim ^a,c   Bouvard, Daniel ^b,c   Sanjay, Archana ^b,c   Marie, Pierre J ^a,c  

^a INSERM   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cbl; FGFR; Osteoblast; Ubiquitination

Indexed keywords

CBL PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; ATTENUATION; CELL MEMBRANE; CELL SURVIVAL; CHEMICAL ANALYSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIPID RAFT; MOLECULAR INTERACTION; OSTEOBLAST; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL LINE; CELL SURVIVAL; HUMANS; MEMBRANE MICRODOMAINS; MUTATION; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 43149123990     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.02.009     Document Type: Article

References (50)

1. Eswarakumar V.P., Lax I., and Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16 (2005) 139-149
2. Ornitz D.M., and Marie P.J. FGF signalling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16 (2002) 1446-1465
3. Marie P.J., Coffin J.D., and Hurley M. FGF and FGFR signaling in chondrodysplasias and craniosynostosis. J Cell Biochem 96 (2005) 888-896
4. Dailey L., Ambrosetti D., Mansukhani A., and Basilico C. Mechanisms underlying differential responses to FGF signaling. Cyokine Growth Factor Rev 16 (2005) 233-247
5. Wilkie A.O. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16 (2005) 187-203
6. Lomri A., Lemonnier J., Hott M., de Parseva N., Lajeunie E., Munnich A., et al. Increased calvarial cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 101 (1998) 1310-1317
7. Fragale A., Tartagli M., Bernardini S., Michela Di Stasi A.M., Di Rocco C., Velardi F., et al. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol 154 (1999) 1465-1477
8. Tanimoto Y., Yokozeki M., Hiura K., Matsumoto K., Nakanishi H., Matsumoto T., et al. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome. J Biol Chem 279 (2004) 45926-45934
9. Baroni T., Carinci P., Lilli C., Bellucci C., Aisa M.C., Scapoli L., et al. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation. J Cell Physiol 202 (2005) 524-535
10. Lemonnier J., Hay E., Delannoy P., Lomri A., Modrowski D., Caverzasio J., et al. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Min Res 16 (2001) 832-845
11. Kaabeche K., Lemonnier J., Le Mée S., Caverzasio J., and Marie P.J. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J Biol Chem 279 (2004) 36259-36267
12. Mansukhani A., Bellosta P., Sahni M., and Basilico C. Signaling by fibroblast growth factors FGF and fibroblast growth factor receptor 2 FGFR2 -activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 149 (2000) 1297-1308
13. Lemonnier J., Haÿ E., Delannoy P., Fromigué O., Lomri A., Modrowski D., et al. Increased osteoblast apoptosis in Apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol 158 (2001) 1833-1842
14. Chen L., Li D., Li C., Engel A., and Deng C.X. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 Fgfr2 results in craniosynostosis. Bone 33 (2003) 169-178
15. Lomri A., Lemonnier J., Delannoy P., and Marie P.J. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5′-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray. J Bone Miner Res 16 (2001) 705-712
16. Kaabeche K., Guenou H., Bouvard D., Didelot N., Listrat A., and Marie P.J. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. J Cell Sci 118 (2005) 1223-1232
17. Rubin C., Gur G., and Yarden Y. Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation. Cell Res 15 (2005) 66-71
18. Thien C.B., and Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2 (2001) 294-307
19. Schmidt M.H., and Dikic I. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 6 (2005) 907-919
20. Swaminathan G., and Tsygankov A.Y. The Cbl family proteins: ring leaders in regulation of cell signaling. J Cell Physiol 209 (2006) 21-43
21. Sanjay A., Horne W.C., and Baron R. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases. Sci STKE 110 (2001) PE40
22. Yokouchi M., Kondo T., Houghton A., Bartkiewicz M., Horne W.C., Zhang H., et al. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem 274 (1999) 31707-31712
23. Tsygankov A.Y., Teckchandani A.M., Feshchenko E.A., and Swaminathan G. Beyond the RING: CBL proteins as multivalent adapters. Oncogene 20 (2001) 6382-6402
24. Horne W.C., Sanjay A., Bruzzaniti A., and Baron R. The roles of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunol Rev 208 (2005) 106-125
25. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1 (2000) 31-39
26. Galbiati F., Razani B., and Lisanti M.P. Emerging themes in lipid rafts and caveolae. Cell 106 (2001) 403-411
27. Miljan E.A., and Bremer E.G. Regulation of growth factor receptors by gangliosides. Sci STKE 160 (2002) RE15
28. L.D. Zajchowski, S.M. Robbins. Lipid rafts and little caves Compartmentalized signalling in membrane microdomains. Eur J Biochem 269, 737-752.
29. Lafont F., and Simons K. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signalling. Proc Natl Acad Sci USA 98 (2001) 3180-3184
30. Niethammer P., Delling M., Sytnyk V., Dityatev A., Fukami K., and Schachner M. Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis. J Cell Biol 157 (2002) 521-532
31. Haglund K., Shimokawa N., Kruh G.D., and Dikic I. Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J Cell Sci 117 (2004) 2557-2568
32. Hunter S., Burton E.A., Wu S.C., and Anderson S.M. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem 274 (1999) 2097-2106
33. Miyazaki T., Sanjay A., Neff L., Tanaka S., Horne W.C., and Baron R. Src kinase activity is essential for osteoclast function. J Biol Chem 279 (2004) 17660-17666
34. Fournier H.N., Dupe-Manet S., Bouvard D., Lacombe M.L., Marie C., Block M.R., et al. Integrin cytoplasmic domain-associated protein 1alpha ICAP-1alpha interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J Biol Chem 277 (2002) 20895-20902
35. Fenteany G., and Schreiber S.L. Lactacystin, proteasome function, and cell fate. J Biol Chem 273 (1998) 8545-8548
36. Mukherjee A., Arnaud L., and Cooper J.A. Lipid-dependent recruitment of neuronal Src to lipid rafts in the brain. J Biol Chem 278 (2003) 40806-40814
37. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev 13 (1999) 2905-2927
38. Liu Y.C., Liu Y., Elly C., Yoshida H., Lipkowitz S., and Altman A. Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif. J Biol Chem 272 (1997) 9979-9985
39. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., and Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell 68 (1992) 673-682
40. Karpen H.E., Bukowski J.T., Hughes T., Gratton J.P., Sessa W.C., and Gailani M.R. The sonic hedgehog receptor patched associates with caveolin-1 in cholesterol-rich microdomains of the plasma membrane. J Biol Chem 276 (2001) 19503-19511
41. Furuchi T., and Anderson R.G. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase ERK. J Biol Chem 273 (1998) 21099-21104
42. Ong S.H., Hadari Y.R., Gotoh N., Guy G.R., Schlessinger J., and Lax I. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc Natl Acad Sci USA 98 (2001) 6074-6079
43. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., and Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286 (1999) 309-312
44. Waterman H., Levkowitz G., Alroy I., and Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J Biol Chem 274 (1999) 22151-22154
45. Davy A., Feuerstein C., and Robbins S.M. Signaling within a caveolae-like membrane microdomain in human neuroblastoma cells in response to fibroblast growth factor. J Neurochem 74 (2000) 676-683
46. Swaminathan G., Feshchenko E.A., and Tsygankov A.Y. c-Cbl-facilitated cytoskeletal effects in v-Abl-transformed fibroblasts are regulated by membrane association of c-Cbl. Oncogene 26 (2007) 4095-4105
47. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
48. Hallmann D., Trumper K., Trusheim H., Ueki K., Kahn C.R., Cantley L.C., et al. Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha. J Biol Chem 278 (2003) 5099-6008
49. Debiais F., Lefevre G., Lemonnier J., Le Mée S., Lasmoles F., Mascarelli F., et al. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent pathway. Exp Cell Res 297 (2004) 235-246
50. Li Y.C., Park M.J., Ye S.K., Kim C.W., and Kim Y.N. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol 168 (2006) 1107-1118 quiz 1404-1105